Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease

被引：19
|
作者：
Townsend, M [1 ]
MacIver, DH [1 ]
机构：
[1] Taunton & Somerset Hosp, Dept Cardiol, Taunton TA1 5DA, Somerset, England
来源：
HEART | 2004年 / 90卷 / 08期
关键词：
D O I：
10.1136/hrt.2004.036236
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 63 year old man with a six year history of Parkinson's disease presented with signs of right heart failure following a knee replacement. Constrictive pericarditis was diagnosed and a radical pericardectomy performed. Six months later, the patient remained unwell with raised inflammatory markers. An inflammatory fibrotic reaction caused by cabergoline was diagnosed. He improved after cessation of cabergoline.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (Cabergoline) for Parkinson's disease
    Ling, LH
    Ahlskog, JE
    Munger, TM
    Limper, AH
    Oh, JK
    MAYO CLINIC PROCEEDINGS, 1999, 74 (04) : 371 - 375
  • [2] A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia
    Londahl, Magnus
    Nilsson, Anders
    Lindgren, Hans
    Katzman, Per
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (04) : 583 - 585
  • [3] Reversible cardiac valve fibrosis secondary to treatment with high-dose cabergoline for Parkinson's disease
    Levin, Johannes
    Neudert, Joachim
    Zwermann, Ludwig
    Naebauer, Michael
    Boetzel, Kai
    JOURNAL OF NEUROLOGY, 2011, 258 (11) : 2097 - 2099
  • [4] Reversible cardiac valve fibrosis secondary to treatment with high-dose cabergoline for Parkinson’s disease
    Johannes Levin
    Joachim Neudert
    Ludwig Zwermann
    Michael Näbauer
    Kai Bötzel
    Journal of Neurology, 2011, 258 : 2097 - 2099
  • [5] Cabergoline in the treatment of Parkinson's disease
    Pastor, P
    Tolosa, E
    NEUROLOGIA, 2003, 18 (04): : 202 - 209
  • [6] Constrictive pericarditis in Parkinson's disease patients treated with pergolide
    Tolar, M
    Gorelick, R
    Feldman, RG
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S32 - S32
  • [7] Multimodal Imaging of Constrictive Pericarditis Induced by Long-term Pergolide Treatment for Parkinson's Disease
    Aoyagi, Hiroyuki
    Tsujinaga, Shingo
    Takahashi, Yuki
    Naito, Seiichiro
    Sato, Takuma
    Otsuka, Takuya
    Tamaki, Yoji
    Motoi, Ko
    Ishizaka, Suguru
    Chiba, Yasuyuki
    Kamiya, Kiwamu
    Iwano, Hiroyuki
    Nagai, Toshiyuki
    Wakasa, Satoru
    Anzai, Toshihisa
    INTERNAL MEDICINE, 2023, 62 (24) : 3637 - 3641
  • [8] Pharmacokinetic evaluation of Cabergoline treatment in Parkinson's disease
    Hatano, T
    Hatano, YS
    Okuma, Y
    Hattori, N
    Mizuno, Y
    MOVEMENT DISORDERS, 2002, 17 : S100 - S100
  • [9] Cabergoline - A review of its use in the treatment of Parkinson's disease
    Curran, MP
    Perry, CM
    DRUGS, 2004, 64 (18) : 2125 - 2141
  • [10] Cabergoline - A review of its efficacy in the treatment of Parkinson's disease
    Wiseman, LR
    Fitton, A
    CNS DRUGS, 1999, 12 (06) : 485 - 497
12345